A Controlled Trial of Rasagiline in Early Parkinson Disease
Top Cited Papers
Open Access
- 1 December 2002
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 59 (12) , 1937-1943
- https://doi.org/10.1001/archneur.59.12.1937
Abstract
Research from JAMA Neurology — A Controlled Trial of Rasagiline in Early Parkinson Disease — The TEMPO StudyKeywords
This publication has 12 references indexed in Scilit:
- Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat.Life Sciences, 2000
- Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouseEuropean Journal of Pharmacology, 1999
- Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkeyPublished by Springer Nature ,1998
- Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disordersPublished by Springer Nature ,1998
- (R)(+)-N-Propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase BPublished by Springer Nature ,1998
- Core assessment program for intracerebral transplantations (CAPIT)Movement Disorders, 1992
- TYRAMINE ANTAGONISTIC PROPERTIES OF AGN 1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE TYPE BBritish Journal of Pharmacology, 1981
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- ParkinsonismNeurology, 1967
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961